BioStem Technologies to Present at the 25th Annual Needham Virtual Healthcare Conference
Author By Sophia VidaPosted on POMPANO BEACH, Fla., March 31, 2026 – PRISM MediaWire (Press Release Service – Press Release Distribution) – BioStem Technologies Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacturing, and commercialization of perinatal tissue allograft products, today announced that Company management will present at the 25th Annual Needham Virtual Healthcare Conference.
BioStem’s management is scheduled to present on Monday, April 13, 2026, at 8:45 am ET. Interested parties may access live and archived webcasts of the presentations on the “investors” section of the Company’s website at: ir.biostemtechnologies.com.
About BioStem Technologies, Inc. (OTC: BSEM): BioStem Technologies is a publicly traded, biomedical innovator, focused on developing, manufacturing and commercializing advanced allograft solutions derived from perinatal tissue. The company leverages its industry-leading proprietary BioRetain®, CryoTek® and SteriTek® processing technologies, designed to optimize the preservation of the natural properties of these tissues, supporting their use in clinical settings. Its allografts are used by clinicians across a wide range of specialties. With a growing portfolio of products, expanding clinical research initiatives, and a national commercial footprint, BioStem is committed to advancing innovation in regenerative medicine.
BioStem Technologies’ quality management system and standard operating procedures have been reviewed and accredited by the American Association of Tissue Banks (“AATB”). These systems and procedures are established in compliance with current Good Tissue Practices (“cGTP”) and current Good Manufacturing Processes (“cGMP”). BioStem’s portfolio of quality brands includes its Neox®, Clarix®, VENDAJE® and American Amnion™ product lines.
For more information, visit biostemtechnologies.com and follow us on X and LinkedIn.
Join BioStem’s Distribution List & Social Media:
To follow the latest developments at BioStem, sign up for the Company’s email distribution list HERE, and follow us on X and LinkedIn.
Contact BioStem:
Website: www.biostemtechnologies.com
E-Mail: pr@biostemtech.com
X: @BSEM_Tech
Facebook: BioStemTechnologies
Phone: 954-380-8342
Investor Relations:
Philip Trip Taylor, Gilmartin
E-Mail: ir@biostemtech.com
Source: BioStem Technologies, Inc.
The latest news and updates relating to $BMES are available in the company’s newsroom at: https://tinyurl.com/bsemnewsroom
PMW on Newsramp: https://newsramp.com/newswire/prism
Add PRISM MediaWire as your preferred news source on Google
The post BioStem Technologies to Present at the 25th Annual Needham Virtual Healthcare Conference first appeared on Prism Media Wire.
